title: The drug-free period: a methodological issue.
authors.affiliation: Department of Psychiatry, Albert Einstein College of Medicine/Montefiore Medical Center, Bronx, New York.
authors.forename: G M
authors.initials: GM
authors.lastname: Asnis
authors.forename: J M
authors.initials: JM
authors.lastname: Harkavy Friedman
authors.forename: N
authors.initials: N
authors.lastname: Iqbal
authors.forename: W K
authors.initials: WK
authors.lastname: Bajwa
authors.forename: O
authors.initials: O
authors.lastname: Kalus
authors.forename: E
authors.initials: E
authors.lastname: Rubinson
authors.forename: D
authors.initials: D
authors.lastname: Grosz
authors.forename: H M
authors.initials: HM
authors.lastname: van Praag
authors.forename: T B
authors.initials: TB
authors.lastname: Cooper
mesh_terms: D001008:Anxiety Disorders / Q000097:blood / Q000188:drug therapy*; D002986:Clinical Trials as Topic; D003866:Depressive Disorder / Q000097:blood / Q000188:drug therapy*; D003891:Desipramine / Q000008:administration & dosage* / Q000493:pharmacokinetics; D004334:Drug Administration Schedule; D005239:Fear / Q000187:drug effects*; D006801:Humans; D006854:Hydrocortisone / Q000097:blood*; D007273:Injections, Intramuscular; D008657:Metabolic Clearance Rate / Q000502:physiology; D010200:Panic / Q000187:drug effects* / Q000502:physiology
chemical_list: D003891:Desipramine; D006854:Hydrocortisone